PHARMAGREEN BIOTECH INC. Financing Receivable, after Allowance for Credit Loss, Current
PHARMAGREEN BIOTECH INC. had Financing Receivable, after Allowance for Credit Loss, Current of $88.85 thousand as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current
us-gaap:NotesAndLoansReceivableNetCurrent · last filed 2023-08-14
- 2023-06-30: Financing Receivable, after Allowance for Credit Loss, Current $88.85K.
- 2023-03-31: Financing Receivable, after Allowance for Credit Loss, Current $88.85K.
- 2022-09-30: Financing Receivable, after Allowance for Credit Loss, Current $0.00.
| Period end | Financing Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2023-06-30 | $88.85K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $88.85K 10-Q · filed 2023-05-19 |
| 2022-09-30 | $0.00 10-Q · filed 2023-08-14 |